Moderna will build its first mRNA production facility in Kenya, investing up to US$500m.
Up To Date
Latest News
IgE cancer antibody specialist Epsilogen Ltd has closed a £30.75m round led by Novartis Venture Fund to...
AbbVie has completed the acquisition of Syndesi Therapeutics SA, which will help to expand AbbVie's...
ADC manufacturer Heidelberg Pharma AG has negotiated a US$931m licensing and investment deal with China's...
Paris-based Meletios Therapeutics SA has licenced know-how from the Institut Pasteur for the development of a...
The European Circular Bioeconomy Fund has announced its final closing at €300m, €50m above its target.